|
[1]
|
CCL24 and Fibrosis: A Narrative Review of Existing Evidence and Mechanisms
Cells,
2025
DOI:10.3390/cells14020105
|
|
|
|
|
[2]
|
The Role of CCL24 in Systemic Sclerosis
Rambam Maimonides Medical Journal,
2023
DOI:10.5041/RMMJ.10504
|
|
|
|
|
[3]
|
Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells
Cells,
2022
DOI:10.3390/cells11030411
|
|
|
|
|
[4]
|
Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells
Cells,
2022
DOI:10.3390/cells11030411
|
|
|
|
|
[5]
|
Tumor Microenvironment
Advances in Experimental Medicine and Biology,
2021
DOI:10.1007/978-3-030-62658-7_7
|
|
|
|
|
[6]
|
A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage
JHEP Reports,
2020
DOI:10.1016/j.jhepr.2019.100064
|
|
|
|
|
[7]
|
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis
Annals of the Rheumatic Diseases,
2019
DOI:10.1136/annrheumdis-2019-215119
|
|
|
|
|
[8]
|
Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis
Annals of the Rheumatic Diseases,
2019
DOI:10.1136/annrheumdis-2019-215119
|
|
|
|
|
[9]
|
Functionalised Cardiovascular Stents
2018
DOI:10.1016/B978-0-08-100496-8.00014-7
|
|
|
|
|
[10]
|
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview
Journal of Scleroderma and Related Disorders,
2017
DOI:10.5301/jsrd.5000226
|
|
|
|
|
[11]
|
Characterisation of the vascular pathology in Sigmodon hispidus (Rodentia: Cricetidae) following experimental infection with Angiostrongylus costaricensis (Nematoda: Metastrongylidae)
Memórias do Instituto Oswaldo Cruz,
2017
DOI:10.1590/0074-02760160124
|
|
|
|
|
[12]
|
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview
Journal of Scleroderma and Related Disorders,
2017
DOI:10.5301/jsrd.5000226
|
|
|
|